NCT04487613 is a Phase 4 clinical trial of Moringa oleifera leaf in Postpartum Women, sponsored by Chulalongkorn University.

Who is sponsoring NCT04487613?

NCT04487613 is sponsored by Chulalongkorn University.

What drugs are being tested in NCT04487613?

Interventions in NCT04487613: Moringa oleifera leaf, Placebo.

What condition does NCT04487613 study?

NCT04487613 studies Postpartum Women.

Is NCT04487613 still recruiting?

NCT04487613 is currently completed. Last updated 8 July 2022.

Last reviewed 2022-07-08 · How we verify

NCT04487613

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Moringa Oleifera Capsule in Increasing Breast Milk Volume in Early Postpartum Patients

Completed Phase 4 Last updated 8 July 2022

What this trial tests

Phase 4 trial testing Moringa oleifera leaf in Postpartum Women in 88 participants. Completed in 30 June 2022.

Timeline

15 March 2021

Primary endpoint
31 May 2022

30 June 2022

Quick facts

Lead sponsor	Chulalongkorn University
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	88
Start date	15 March 2021
Primary completion	31 May 2022
Estimated completion	30 June 2022
Sites	1 location across Thailand

Drugs / interventions tested

Moringa oleifera leaf — full drug profile →
Placebo

Conditions studied

Postpartum Women — all drugs for Postpartum Women →

Sponsor

Chulalongkorn University

Who can join

18 and older, female only, with Postpartum Women. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the effect of Moringa oleifera leaf capsule in increasing breast milk volume

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The effect of Moringa oleifera capsule in increasing breastmilk volume in early postpartum patients: A double-blind, randomized controlled trial.
Fungtammasan S, Phupong V. · · 2021 · cited 11× · PMID 33822798 · DOI 10.1371/journal.pone.0248950
The effect of Moringa oleifera capsule in increasing breast milk volume in early postpartum patients: A double-blind, randomized controlled trial.
Fungtammasan S, Phupong V. · · 2022 · cited 3× · PMID 36440058 · DOI 10.1016/j.eurox.2022.100171
The "Colors" of Moringa: Biotechnological Approaches.
Villegas-Vazquez EY, Padilla-Mendoza JR, Carrillo-Pérez MS, Gómez-Cansino R, et al · · 2025 · PMID 40805688 · DOI 10.3390/plants14152338

Verify or expand the search:

Other trials of Moringa oleifera leaf

Trials testing the same drug.

NCT05390099 — Anti-Plaque and Anti-Gingivitis Effects of Moringa Plant Extract and Fluoride Toothpastes · NA · unknown

Other Chulalongkorn University trials

Trials by the same sponsor.

NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
NCT07373977 — Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Ma · EARLY_PHASE1 · not yet recruiting
NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04487613 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
Last refreshed: 8 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04487613.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing